key: cord-0702912-2cmwvs8e authors: Udaya kumar, V.; Pavan, Garapati; Murti, Krishna; Rahul kumar,; Dhingra, Sameer; Haque, Mainul; Ravichandiran, V. title: Rays of immunity: Role of sunshine Vitamin in management of COVID-19 infection and associated comorbidities date: 2021-09-27 journal: Clin Nutr ESPEN DOI: 10.1016/j.clnesp.2021.09.727 sha: a7e81a0583a66c145996dc0df7dd3b422a8503a4 doc_id: 702912 cord_uid: 2cmwvs8e The catastrophic pandemic engendered due to the Novel coronavirus (COVID-19) outbreak which causes severe clinical afflictions on the respiratory system has severely high morbidity and mortality rates. The requirement of novel compounds is at utmost importance due to lack of targeted drug molecule to treat the afflictions and restrict the viral infection and for the usage of prophylactic treatment to avoid the spread of the infection is of utmost importance. Vitamin D is one such naturally available multifunctional molecule, which plays an eminent role in the immune system and instigation of numerous cellular pathways further promoting health benefits and enhancing the human quality of life. This article reviews the current standpoint scenario and future prevalence of vitamin D supplementation in the management of covid-19 patients. Novel findings of Vitamin D suggest that along with regulation of cell growth, neuroprotective and mood-stabilizing effects, it regulates the immune response also modulate cytokine Interleukin-6 (IL-6) by inducing progesterone-induced blocking factor (PIBF), given the IL-6 levels are considerably high in COVID-19 patients which increases the further complications. Vitamin D also have its effect on angiotensin converting enzyme (ACEII) inhibitor through which the COVID-19 virus makes cell entry. Numerous research data elucidate the play of Vitamin D, in complications of COVID-19 including the most common comorbid conditions, neurological manifestations and immunological aspects makes it an ideal molecule for adjuvant therapy. Including Vitamin D as add-on therapy in the management of COVID-19 might aid the arrest of infection and helps fight this arduous epidemic. Malnutrition includes both over and under nutrition, vitamin, mineral deficiency and obesity lead to poor health outcomes. Malnutrition has a noteworthy effect in COVID-19, the current pandemic situation has gradually increased the prevalence of malnutrition due to lack of job opportunities and work because of the lockdowns and decreased quality of food (17 19) . Co incidentally the population groups with these diseases are at higher risk for COVID-19 infection. Low-mid income countries were likely to increase double burden of malnutrition due of lack of access to the nutrition food. (20) studies suggest that majority of population infected from COVID were severely suffering from malnutrition and minor population were at risk of malnutrition (21, 22) . (24) . Micro nutrients such as vitamins provide various cellular, physiological and pharmacological effects including instating immune defence, cell repair, proliferation, antioxidant effects which will play a major key role in prevention of infection and can also be used as adjuvant therapy in the management of COVID-19 (25) . This article reviews the importance of a trace element Vitamin D and its significance in the management of COVID-19 and its associated comorbid conditions. Vitamin D deficiency or hypovitaminosis D is a pressing health predicament that needs to be solved since it increases the risks of many diseases. In the current pandemic situation, immuneboosting molecules play a prominent role in maintaining physical and mental health. Vitamin D provides many other health benefits among which regulation of the immune system, body functioning, cell proliferation are major roles. Vitamin D deficiency is considered when the serum/plasma Vitamin D level is below 75 nmol/L (or 30 ng/ml) of concentration (26, 27) . Spain (31) . Furthermore, countries such as India, Pakistan, and Bangladesh recorded higher number of COVID-19 cases Reduced sun exposure and dietary variables are among the top causes for hypovitaminosis D. Solar exposure in winters is less compared to summer, circumvent of sun exposure can also because prolonged days in higher altitudes and high temperatures. In women it is due to application of cosmetics and extensive clothing (32) (33) (34) . Hypovitaminosis D in winter was more in women (36%) than men (9%). Physical endurance was also positively influenced by vitamin D (35) . The ubiquity of vitamin D deficiency is 35% in obese population than others among geriatric, and hospitalized patients(36 Better lung function also decreased respiratory infections was observed in adult males compared to women with higher Vitamin D levels, which varied throughout seasons. Vitamin D was explored well for its effects in various viral diseases. Antiviral effect of Vitamin D is explored broadly in numerous viral infections. Calcitriol synergize with interferon-alpha to constrain Hepatitis C virus viral development (79) . In population with congestive heart block (CHB), low Vitamin D serum levels are related to increased hepatitis B virus (HBV) replication. This is a big deviation from chronic hepatitis C, where there has been an absence of association between HCV viral load and Vitamin D serum levels in many previous studies (87). findings indicate through autophagy-and CAMP-dependent mechanism Vitamin D3 inhibits, Replication of both TB and HIV in human macrophages (88) . In reaction to influenza vaccine, Vit-D supplementation encourages a higher TGFβ plasma level. This supplementation tends to steer the polarization of the lymphocyte into a tolerogenic immune response (89) . There is colossal amount of corroboration which justifies the multipurpose properties of Vitamin D supplementation/ Vitamin D receptors. A systematic review stated that It is actively explored to use as add-on therapy in the management of numerous infectious diseases (90) . The there was 54% increased positivity rate in population whose circulating level was <20ng/ml (96, 97) . In a study of 185 patients 64% had Vitamin D levels lower than 20ng/ml and 22% had less than 12ng/ml where 50% of total population required hospitalization and observed lesser mean vitamin D status (18.2). Another half did not need hospitalization and had comparatively higher mean vitamin D status, the IL-6 levels were prominently increased in hospitalized patientsdue to COVID-19 infection (98) . In a novel study of feeble geriatric patients who were tested with COVID -19 infection, the bolus vitamin D3 supplementation expressed a clinically relevant defensive effect when taken right before COVID-19. It is also related to decreased severity and improved survival rate (99) . A meta-analysis revealed patients with low serum levels were 1.5 times more prone to be infected with COVID-19. The systematic review concluded no outcome exposed a strong relation between Vitamin D and COVID-19 recovery. [108] Another systematic review found a significant relationship between vitamin D concentration and COVID-19 infection. [109] Low serum vitamin D levels were associated with a high rate of infection, severity and mortality. [110] All these systematic reviews are limited by insufficient data availability, heterogenicity among study types. An ongoing clinical trial to evaluate the efficacy and safety of Vitamin D in COVID-19 patients. This randomised controlled trial involves up to 6 weeks of the treatment period with 25,000 IU/mL of cholecalciferol. The upcoming results of this trial may provide knowledge that can help to improve the COVID-19 health-related outcomes. [111] Another clinical trial to assess the Vitamin D daily dietary intake and COVID-19 severity among newly diagnosed patients also infection risk reduction among household contacts of newly diagnosed patients. [112] These trials can overcome all the limitations of the above-mentioned systematic reviews. A study concluded that a reported corona virus infection was found in 41 patients admitted to the hospital most of the infected were male with less than half of them having underlying diseases particularly diabetes, hypertension and cardiovascular diseases(4). The dodgiest co morbid condition being cardiovascular disease followed by chronic respiratory diseases (2) . A published study of meta-analysis revealed that most prevalent coronary metabolic comorbidities were hypertension, cardiac cerebrovascular disease, accompanied by diabetes (113) . Acute cardiac injury and acute arrhythmia and congestive heart failure (CHF) are among the top cardiac difficulties of COVID-19. A group of 10 out of 138 COVID-19 positive patients had acute heart injury and 23 more experienced acute arrhythmia (114) . Heart failure is one of the chief reasons of COVID-19 disease fatalities. Heart disease accounted for 23% of deaths in a study of 813 patients (115) . Pre-existent comorbidities in older infected patients includes coronary artery disease, hypertension and diabetes. Heart failure can be the outcome of alleviation of these prior conditions, whether diagnosed or unexplained, or subclinical cardiac dysfunction. In specific, diastolic dysfunction can develop cardiac insufficiency caused by high fever, tachycardia, impaired renal function and excessive hydration in geriatric population (116) . Instant inflammatory reaction does not occur due to dysregulation of immune responses, in people with cardiometabolic diseases as the drugs such as ACE inhibitors leads to over expression of ACE2 receptors further related to SARS-CoV-2 virus body entry. This promotes a delayed immune response and induces cytokine storm further increase the complication. Vitamin D receptors can regulate the ACE2 receptors. (117) . ACE2 deficiency is also associated with worsening hypertension and cardiac hypertrophy, which is induced by angiotensin II(118). ACE2 is commonly expressed, controls the fundamental cellular biology of cardiomyocytes, cardio fibroblasts and coronary endothelial cells. In addition, ACE2 deficiency causes patients to be more prone to heart failure due to either inhibition or deletion as a causative outcome for associated with medications may also lead to acute kidney injury (122) . The findings of prephase clinical trials have revealed that Vitamin D appears to be a possible regulator of pancreatic β-cell insulin secretion, Ca2+ level. Along with few others genes associated in cytoskeletal organisation, intracellular joints and pancreatic beta cell-growth. Vitamin D receptors also contributed to insulin gene transcription (123) . Numerous reports have publicized that hypovitaminosis D in pancreatic β-cells leads to failure of the glucose mediated insulin secrition. It has also been documented that through vitamin D supplementation, insulin secretion appears to be restored (124) . acknowledged in the pancreatic beta-cells of the insulin gene promoter (125) . The findings of several scientific trials have exposed that supplementation of vitamin D has been related to enhancing insulin secretion (33, 126) . Vitamin D also exerts anti-coagulant activity by decreasing tissue factor levels and escalates the level of thrombomodulin, (127) Few studies were solemnly focused, on the neurological conditions of SARS-CoV-2 has substantial evidence of the happenings(132) A meta-analysis of 409 patients to assess the neurological disorders, headaches being most common followed by dizziness, impaired consciousness, vomiting, seizures, neuralgia, and ataxia were the key physiological adjustments (133) . SARS-CoV-2 is also dependent on ACE2 for cellular tropism and replication very similar to SARS -CoV infection (134) . In many unique brain regions in humans, ACE2 expression was moderately high. The expression of ACE2 in humans is primarily present in both neurons of excitation, moderate ACE2 cells were found in hippocampus and absent in Pre frontal cortex (135) . The associations with ACE2 in different and specific brain sections would give the viral organism the ability to infect the neural network of COVID19 patients if the organism were to cross the blood brain barrier (BBB) over the process of continuous infection (136) . Dopa Decarboxylase (DDC) is a pivotal enzyme that may also have a potential functional interaction between ACE2-mediated angiotensin synthesis(71). SARS-CoV-2 might also affect the cell populations of neuronal progenitor cells. Since, these cells could be compromised by COVID-19 infection. The regeneration of olfactory activity and other neurological symptoms could be incomplete and late (137) . The expression of ACE2 in various organ systems and exposure to other elements of the renin angiotensin system (RAS) like nicotine imply that nicotinic acetylcholine receptor (nAChR) signalling will facilitate COVID-19 cellular entry. In fact, several of the similar cells that produce ACE2 in the pulmonary organs, liver, blood, and brain are known to have nAChRs (136) . Calcitriol regulates ACE2 and ACE expression (138) . Encephalomyelitis (EAE) is a rare, mostly post-viral, demyelinating condition that is more frequently seen in children, but rarely in adults. It was also observed in patients tested oppositive with COVID-19 infection as a vague comorbid condition. An immuno-inhibitory cellular and humoral reaction of Vitamin D3 in vivo was demonstrated in an experimental rat model in the autoimmune encephalomyelitis research (141, 142) . Vitamin D3 reversibly prevents EAE progression and that EAE initiation is exacerbated by vitamin D deficiency deliver ample proof that solemnly Vitamin D presence can be a significant feature in deciding the occurrence of MS and that it is a modulator of the immune system which is physiologically significant (133) . Vitamin D influences production of nerve growth factor (NGF), brain derived neurotrophic factor (BNDF) and exhibits a neurotropic effect (134, 145) . Vitamin D specifically controls the expression of C-Ret, a multifunctional receptor essential for the signalling of Glial Mediated neurotrophic factor in dopaminergic neurons (146) . Since, SARS-CoV has mostly reached and dispersed all over the brain via the olfactory nerve, causing nerve damage (147) . The effect of vitamin-D in multiple cardiovascular disorders where vitamin -d deficiency is inversely proportional to the economic burden and reduction in overall mortality cause [150, 151] followed by hypertension, [152] ischemic heart disease and myocardial infraction [153] and various cardio vascular diseases. [154] . The anti-thrombotic properties of Vitamin to the emergence of deep venous thromboembolic (DVT) [155] incidents in individuals with ischemic stroke and idiopathic lower-extremity [156] . Similarly, 40% of unprovoked venous thromboembolism cases were due to vitamin-D deficiency where majority are women [157, 158] . In obese individuals, a study found a sexually dimorphic influence of vitamin D level correction on proteins implicated in blood coagulation, with men having greater circulating quantities of proteins associated with the blood coagulation pathway than women. Males convert 25-hydroxyvitamin D to the active metabolite 1,25-hydroxyvitamin D at a higher rate than women, as evidenced by protein levels. These characteristics could be attributed to the impact of sex hormone metabolism on vitamin D levels. [159] similarly, downregulates the expression of a critical coagulation factor, tissue factor counteracting the influence of tumour necrosis factor. [162] furtherly the association between haemostatic markers such as von Willebrand factor, D-dimer, highly sensitive C-reactive protein and tissue plasminogen activator was found to be inverse with serum 25(OH)D level. [163] Given the heterogeneity and small number of clinical studies, more study is needed to better understand the haemostatic abnormalities seen in vitamin D3 deficient people, as well as to determine the potential benefits of vitamin D3 supplementation on coagulation and haemostasis. Hypocalcaemia is associated with low vitamin D levels and leading to thoracic vertebral fracture among COVID-19 patients. This is a common osteo-metabolic comorbidity among COVID patients, which implies the importance of calcium and vitamin D supplementation to improve health outcomes. [164, 165] WHO. WHO Coronavirus (COVID-19) Dashboard 2021 Estimation of risk factors for COVID-19 Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19 Metabolism of vitamin D2 and vitamin D3 in patients on anticonvulsant therapy Anticonvulsant action" of vitamin D in epileptic patients? A controlled pilot study When a pandemic and an epidemic collide: COVID-19, gut microbiota, and the double burden of malnutrition Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China Prevalence and severity of malnutrition in hospitalized COVID-19 patients Malnutrition Care during the COVID-19 Pandemic: Considerations for Registered Dietitian Nutritionists Evidence Analysis Center Obesity, malnutrition, and trace element deficiency in the coronavirus disease (COVID-19) pandemic: An overview Could Vitamins Help in the Fight Against COVID-19? The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know Vitamin D deficiency in Europe: pandemic? Is vitamin D deficiency a major global public health problem? Inappropriate serum levels of retinol, alpha-tocopherol, 25 hydroxyvitamin D3 and 24,25 dihydroxyvitamin D3 levels in healthy Spanish adults: simultaneous assessment by HPLC Hydroxyvitamin D in Countries from the Middle East and Europe: The Roles of UVB Exposure and Diet The problems of vitamin d insufficiency in older people Vitamin-D and COVID-19: do deficient risk a poorer outcome? The Lancet Diabetes & Endocrinology Influence of Vitamin D Supplementation by Sunlight or Oral D3 on Exercise Performance Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7, MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis A novel 1,25-dihydroxyvitamin D-activin A pathway in human alveolar macrophages is dysfunctional in patients with pulmonary alveolar proteinosis (PAP) Vitamin D attenuates lung injury via stimulating epithelial repair, reducing epithelial cell apoptosis and inhibits TGF-beta induced epithelial to mesenchymal transition Effect of vitamin D3 supplementation on TNF-α serum level and disease activity index in Gastroenterology and Hepatology from bed to bench Vitamin D/VDR signaling attenuates lipopolysaccharideinduced acute lung injury by maintaining the integrity of the pulmonary epithelial barrier VDR attenuates acute lung injury by blocking Ang-2-Tie-2 pathway and renin-angiotensin system Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis Serum vitamin D levels are positively associated with varicella zoster immunity in chronic dialysis patients Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients Deficiency of Vitamin D in HIV Infected Patients and Its Effect on Some of the Immunological Parameters and post-treatment suppresses inflammatory response to influenza A (H1N1) infection in human lung A549 epithelial cells Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebocontrolled, study (SHADE study) Vitamin D supplementation for prevention of mortality in adults. Cochrane database of systematic reviews Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction -A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels Lower levels of vitamin D are associated with SARS-CoV-2 infection and mortality in the Indian population: An observational study Vitamin D Deficiency and Outcome of COVID-19 Patients Vitamin D and survival in COVID-19 patients: A quasi-experimental study Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis Vitamin D insufficiency as a potential culprit in critical COVID-19 patients predictive value of CCL2/MCP-1. Open forum infectious diseases Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients Effects of vitamin D supplementation on circulatory YKL-40 and MCP-1 biomarkers associated with vascular diabetic complications: A randomized, placebo-controlled, doubleblind clinical trial The study of vitamin D administration effect on CRP and Interleukin-6 as prognostic biomarkers of ventilator associated pneumonia Synergistic effect of vitamin D and remdesivir can fight COVID The link between COVID-19 and VItamin D (VIVID): a systematic review and meta-analysis Association of vitamin D status with SARS-CoV-2 infection or COVID-19 severity: a systematic review and meta-analysis. Advances in Nutrition Low serum 25-hydroxyvitamin D (vitamin D) level is associated with susceptibility to COVID-19, severity, and mortality: a systematic review and meta-analysis. Frontiers in Nutrition Effect of Vitamin D on Hospitalized Adults With Infection -Full Text View -ClinicalTrials.gov Vitamin D and COVID-19 Trial -Full Text View -ClinicalTrials.gov Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet COVID-19 Illness and Heart Failure: A Missing Link? Mechanism of inflammatory response in associated comorbidities in COVID Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Risk factors for COVID-19 death in a population cohort study from the Western Cape Province Clinical infectious diseases: an official publication of the Infectious Diseases Society of America Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China Unraveling the effects of 1,25OH2D3 on global gene expression in pancreatic islets Analysis of Association between Vitamin D Deficiency and Insulin Resistance Vitamin D and pancreas: The role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer Vitamin D deficiency inhibits pancreatic secretion of insulin Anticoagulant Effects of 1α,25-Dihydroxyvitamin D3 on Human Myelogenous Leukemia Cells and Monocytes Olfactory and gustatory dysfunctions in COVID-19 patients: a systematic review and meta-analysis Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review Neurological manifestations of COVID-19 and other coronaviruses: A systematic review Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. The Lancet Microbe The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk SARS-CoV-2 infects human neural progenitor cells and brain organoids Calcitriol regulates angiotensinconverting enzyme and angiotensin converting-enzyme 2 in diabetic kidney disease A brief review of interplay between vitamin D and angiotensinconverting enzyme 2: Implications for a potential treatment for COVID-19 Correction of vitamin D deficiency improves seizure control in epilepsy: a pilot study COVID-19-associated acute disseminated encephalomyelitis (ADEM) 1, 25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis 25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells Protective effects of vitamin D on neurophysiologic alterations in brain aging: role of brain-derived neurotrophic factor (BDNF) Vitamin D regulation of GDNF/Ret signaling in dopaminergic neurons Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2 Vitamin D increases remyelination by promoting oligodendrocyte lineage differentiation An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19 Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe. Progress in biophysics and molecular biology An estimate of the economic burden and premature deaths due to vitamin D deficiency in Canada. Molecular nutrition & food research Plasma 25-hydroxyvitamin D levels and risk of incident hypertension 25-hydroxyvitamin d levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arteriosclerosis, thrombosis, and vascular biology New England journal of medicine The relationship between vitamin D status and idiopathic lower-extremity deep vein thrombosis Low vitamin D levels are associated with the development of deep venous thromboembolic events in patients with ischemic stroke. Clinical and applied thrombosis/hemostasis The effect of calcium plus vitamin D supplementation on the risk of venous thromboembolism Emerging role of vitamin D and its associated molecules in pathways related to pathogenesis of thrombosis Sex-specific vitamin D effects on blood coagulation among overweight adults Manifestations of blood coagulation and its relation to clinical outcomes in severe COVID-19 patients: Retrospective analysis Decreased antiinflammatory responses to vitamin D in neonatal neutrophils Anticoagulant effects of 1α, 25-dihydroxyvitamin D3 on human myelogenous leukemia cells and monocytes. Blood, The Journal of the 25-Hydroxyvitamin D and pre-clinical alterations in inflammatory and hemostatic markers: a cross sectional analysis in the 1958 The emerging osteo-metabolic phenotype of COVID-19: clinical and pathophysiological aspects Hypocalcemia is associated with severe COVID-19: A systematic review and meta-analysis Authors would like to express the gratitude towards the faculty of National institute of pharmaceutical education and research-Hajipur. Funding statement: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.